Sterling Capital Management LLC lifted its stake in shares of Humana Inc (NYSE:HUM) by 37.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 9,070 shares of the insurance provider’s stock after acquiring an additional 2,480 shares during the period. Sterling Capital Management LLC’s holdings in Humana were worth $3,070,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Willingdon Wealth Management bought a new stake in shares of Humana during the 3rd quarter worth $186,000. Cognios Capital LLC bought a new stake in shares of Humana during the 3rd quarter worth $1,204,000. Parallel Advisors LLC lifted its holdings in shares of Humana by 116.3% during the 3rd quarter. Parallel Advisors LLC now owns 1,629 shares of the insurance provider’s stock worth $551,000 after acquiring an additional 876 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Humana by 22.1% during the 3rd quarter. Victory Capital Management Inc. now owns 18,779 shares of the insurance provider’s stock worth $6,357,000 after acquiring an additional 3,397 shares during the last quarter. Finally, US Bancorp DE lifted its holdings in shares of Humana by 3.8% during the 3rd quarter. US Bancorp DE now owns 42,529 shares of the insurance provider’s stock worth $14,397,000 after acquiring an additional 1,567 shares during the last quarter. 92.62% of the stock is owned by institutional investors.
In other Humana news, insider Elizabeth D. Bierbower sold 3,092 shares of the business’s stock in a transaction dated Thursday, August 16th. The shares were sold at an average price of $330.00, for a total value of $1,020,360.00. Following the transaction, the insider now owns 14,289 shares in the company, valued at $4,715,370. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bruce D. Broussard sold 18,000 shares of the business’s stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the completion of the transaction, the chief executive officer now owns 71,085 shares in the company, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.
A number of research firms have recently issued reports on HUM. Piper Jaffray Companies lifted their price objective on shares of Humana from $355.00 to $380.00 and gave the stock an “overweight” rating in a report on Friday, August 24th. Bank of America lifted their price objective on shares of Humana from $338.00 to $375.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Royal Bank of Canada reaffirmed a “hold” rating and set a $318.00 price objective on shares of Humana in a report on Thursday, August 2nd. SunTrust Banks lifted their target price on shares of Humana to $380.00 and gave the stock a “hold” rating in a research report on Wednesday, September 19th. Finally, Jefferies Financial Group lifted their target price on shares of Humana from $356.00 to $372.00 and gave the stock a “buy” rating in a research report on Thursday, August 2nd. Seven research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $339.79.
Shares of NYSE:HUM opened at $331.81 on Wednesday. The firm has a market capitalization of $44.50 billion, a P/E ratio of 28.34, a price-to-earnings-growth ratio of 1.61 and a beta of 1.03. Humana Inc has a 52 week low of $231.90 and a 52 week high of $341.30. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.43 and a current ratio of 1.43.
Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, topping analysts’ consensus estimates of $4.29 by $0.29. Humana had a net margin of 2.48% and a return on equity of 17.43%. During the same period in the previous year, the firm posted $3.39 EPS. As a group, equities analysts forecast that Humana Inc will post 14.18 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 25th. Shareholders of record on Monday, December 31st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Friday, December 28th. Humana’s payout ratio is 17.08%.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2018/11/07/humana-inc-hum-shares-bought-by-sterling-capital-management-llc.html.
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.
Further Reading: Hedge Funds Explained
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.